Live
- RAPO22: Bhagyashri Borse Cast Opposite Ram Pothineni in P Mahesh Babu's Upcoming Film
- Gold rates in Delhi today surged, check the rates on 22 November, 2024
- Constitution Day 2024: Celebrating India’s Democratic Legacy
- Women movement turns village sober
- The Hetero Institute of Pharmaceutical Sciences
- Final Hearing for Aishwarya Rajinikanth and Dhanush Divorce Set for November 27
- Drug abuse alarming among children in Kadapa: MLA Madhavi Reddy
- Irregularities in garbage tax collection to be probed
- US DoJ Charges Adani Group Over False Statements and Bribery Allegations, Shares and Bonds Drop
- Gold rates in Hyderabad today surges, check the rates on 22 November, 2024
IIT Delhi transfers 2 indigenous health technologies to industry
Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
New Delhi: Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
The technologies aim to detect prostate cancer and infectious pathogens early.
DNA Aptamer for prostate cancer detection was transferred to Swapnil Sinha, HUMMSA Biotech, Kolkata, and photonic chip-based spectrometric biosensor technology for pathogen detection was given to Nitin Zaveri, UNINO Healthcare, Mumbai.
Developed under the MeitY-funded project called Nanoelectronics Network for Research and Applications (NNetRA), the technologies were transferred on July 31, at an event hosted by the Indian Institute of Technology Delhi.
"We envision a future where technology transfer drives innovation, collaboration, and sustainable development. Measures should be taken to ensure successful adoption, implementation, and commercialisation of technology," said S. Krishnan, Secretary, MeitY.
The aptamer, developed by Prashant Mishra and team from IIT Delhi is capable of binding to the specific oncogenes and could be useful as theranostics for prostate cancer.
On the other hand, the spectrometric biosensor was developed by Joby Joseph and the team from IIT Delhi. It will enable quick and accurate detection of pathogens, thereby aiding in preventing infectious diseases.
